159 related articles for article (PubMed ID: 17237271)
41. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane).
Chakravarti N; Myers JN; Aggarwal BB
Int J Cancer; 2006 Sep; 119(6):1268-75. PubMed ID: 16642480
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
43. [IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].
Liu C; Xie C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):870-5. PubMed ID: 27363263
[TBL] [Abstract][Full Text] [Related]
44. Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
Li R; Yanjiao G; Wubin H; Yue W; Jianhua H; Huachuan Z; Rongjian S; Zhidong L
Oncotarget; 2017 Mar; 8(12):19354-19364. PubMed ID: 28423613
[TBL] [Abstract][Full Text] [Related]
45. Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma.
Mohan CD; Kim C; Siveen KS; Manu KA; Rangappa S; Chinnathambi A; Alharbi SA; Rangappa KS; Kumar AP; Ahn KS
IUBMB Life; 2021 Nov; 73(11):1348-1362. PubMed ID: 34514729
[TBL] [Abstract][Full Text] [Related]
46. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
47. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway.
Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M
Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189
[TBL] [Abstract][Full Text] [Related]
48. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
Liu Y; Liu A; Xu Z; Yu W; Wang H; Li C; Lin J
Apoptosis; 2011 May; 16(5):502-10. PubMed ID: 21311975
[TBL] [Abstract][Full Text] [Related]
49. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
50. Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.
Amit-Vazina M; Shishodia S; Harris D; Van Q; Wang M; Weber D; Alexanian R; Talpaz M; Aggarwal BB; Estrov Z
Br J Cancer; 2005 Jul; 93(1):70-80. PubMed ID: 15970928
[TBL] [Abstract][Full Text] [Related]
51. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
Pei T; Meng Q; Han J; Sun H; Li L; Song R; Sun B; Pan S; Liang D; Liu L
Oncotarget; 2016 Jul; 7(28):43475-43491. PubMed ID: 27259268
[TBL] [Abstract][Full Text] [Related]
52. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
He B; Peng F; Li W; Jiang Y
J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989
[TBL] [Abstract][Full Text] [Related]
53. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma.
Lee JH; Lee H; Yun SM; Jung KH; Jeong Y; Yan HH; Hong S; Hong SS
Cancer Lett; 2013 Feb; 329(1):99-108. PubMed ID: 23142281
[TBL] [Abstract][Full Text] [Related]
54. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Tan SM; Li F; Rajendran P; Kumar AP; Hui KM; Sethi G
J Pharmacol Exp Ther; 2010 Jul; 334(1):285-93. PubMed ID: 20378717
[TBL] [Abstract][Full Text] [Related]
55. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
56. Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells.
Siveen KS; Nguyen AH; Lee JH; Li F; Singh SS; Kumar AP; Low G; Jha S; Tergaonkar V; Ahn KS; Sethi G
Br J Cancer; 2014 Sep; 111(7):1327-37. PubMed ID: 25101566
[TBL] [Abstract][Full Text] [Related]
57. Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma.
Kunter I; Erdal E; Nart D; Yilmaz F; Karademir S; Sagol O; Atabey N
Oncol Rep; 2014 Feb; 31(2):573-80. PubMed ID: 24337632
[TBL] [Abstract][Full Text] [Related]
58. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
Zhang B; Yin X; Sui S
Oncol Rep; 2018 Nov; 40(5):2758-2765. PubMed ID: 30132535
[TBL] [Abstract][Full Text] [Related]
59. Sunitinib induces apoptosis and growth arrest of medulloblastoma tumor cells by inhibiting STAT3 and AKT signaling pathways.
Yang F; Jove V; Xin H; Hedvat M; Van Meter TE; Yu H
Mol Cancer Res; 2010 Jan; 8(1):35-45. PubMed ID: 20053726
[TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma.
Liu Y; Feng J; Sun M; Yang G; Yuan H; Wang Y; Bu Y; Zhao M; Zhang S; Zhang X
Cancer Lett; 2019 Jul; 454():158-170. PubMed ID: 30981758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
